ACM
ORKA

ADAR1 Capital Management’s Oruka Therapeutics ORKA Stock Holding History

ADAR1 Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Hold
20,840
– – 0.06% 160
2025
Q4 		$632K Hold
20,840
– – 0.05% 173
2025
Q3 		$401K Sell
20,840
-121,940
-85% -$1.81M 0.04% 151
2025
Q2 		$1.6M Buy
142,780
+10,000
+8% +$104K 0.25% 64
2025
Q1 		$1.36M Buy
+132,780
New +$1.66M 0.25% 70
2024
Q4 		– Sell
-11,187
Closed -$274K – 315
2024
Q3 		$274K Buy
11,187
+4,131
+59% +$144K 0.04% 148
2024
Q2 		$324K Buy
+7,056
New +$281K 0.06% 123

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

ADAR1 Capital Management's ORKA Position: Q1 2026 in Review

ADAR1 Capital Management held its Oruka Therapeutics (ORKA) position steady in Q1 2026 at 20,840 shares worth $1.02M. The position accounts for 0.06% of the portfolio, ranked #160.

ADAR1 Capital Management first reported a position in ORKA in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.6M in Q2 2025. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • ADAR1 Capital Management held 20,840 shares of Oruka Therapeutics worth $1.02M as of Q1 2026.
  • ADAR1 Capital Management left its Oruka Therapeutics share count unchanged in Q1 2026.
  • Oruka Therapeutics made up 0.06% of ADAR1 Capital Management's portfolio in Q1 2026, its #160 holding.
  • ADAR1 Capital Management first reported a position in Oruka Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • ADAR1 Capital Management's Oruka Therapeutics position peaked at $1.6M in Q2 2025.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.